mesalamine - CISMeF

Preferred Label : mesalamine;

MeSH definition : An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed);

MeSH synonym : meta-aminosalicylic acid; mesalazine; meta aminosalicylic acid; m aminosalicylic acid; m-aminosalicylic acid; 5-aminosalicylic acid; 5 aminosalicylic acid;

CISMeF synonym : celltech brand of mesalamine; sanofi synthelabo brand of mesalamine; henning berlin brand of mesalamine; salofalk; provalis brand of mesalamine; falk brand of mesalamine; farmasa brand of mesalamine; axcan brand of mesalamine; antigen brand of mesalamine; SmithKline brand of mesalamine; merckle brand of mesalamine; norgine brand of mesalamine; Schering-Plough brand of mesalamine; schering plough brand of mesalamine; GlaxoSmithKline brand of mesalamine; Novo5 ASA; novopharm brand of mesalamine; ferring brand of mesalamine; yamanouchi brand of mesalamine; allphar brand of mesalamine; solvay brand of mesalamine; procter & gamble brand of mesalamine; byk brand of mesalamine;

DeCS synonym : Salofalk;

MeSH hyponym : asacolon; rowasa; pentasa; Novo-5 ASA; Mesalamine Monosodium Salt; ascolitin; 5-Aminosalicylate; canasa; mesalamine hydrochloride; claversal; lixacol; fivasa; mesasal; asacol; Hydrochloride, Mesalamine; Monosodium Salt, Mesalamine; Novo 5 ASA; 5 Aminosalicylate;

MeSH Related Number : mesalamine hydrochloride; mesalamine monosodium salt; 35589-28-7 (mono-Na salt); 6291-36-7 (HCl); 89-57-6 (Mesalamine);

Registry Number MeSH : 89-57-6;

Related CAS MeSH : 6291-36-7 (Mesalamine hydrochloride); 35589-28-7 (Mesalamine monosodium salt);

Wikipedia link : https://en.wikipedia.org/wiki/Mesalazine;

Codes EINECS : 201-919-1;

Is substance : O;

medicament (CISMeF) : O;

UNII : 4Q81I59GXC;

InChIKey : KBOPZPXVLCULAV-UHFFFAOYSA-N;

Details

Origin ID

D019804;

UMLS CUI

C0127615;

ATC code(s)
- mesalazine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Aminosalicylic Acid [NCIt concept]
- Aminosalicylic acid (substance) [Inactive SNOMED CT concept]
- Product containing para-aminosalicylic acid (medicinal product) [SNOMED CT concept]
- aminosalicylic acid [ATC Code]
- aminosalicylic acid [SNOMED Notion]
- sodium 5-aminosalicylate [Substance BNPC]
CISMeF manual mappings
- 5-aminosalicylic acid [Substance BNPC]
- 5-aminosalicylic acid poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Mesalamine [NCIt concept]
- Mesalazine [ICD-11 Extension code]
- Mesalazine [ICHI extension code]
- Mesalazine [SMS substance]
- Mesalazine (substance) [SNOMED CT concept]
- mesalamine [SNOMED Notion]
Pharmacological action(s)
- anti-inflammatory agents, non-steroidal [MeSH Descriptor]
Record concept(s)
- 5-Aminosalicylate [MeSH concept]
- Mesalamine Monosodium Salt [MeSH concept]
- Novo-5 ASA [MeSH concept]
- Salofalk [MeSH concept]
- asacol [MeSH concept]
- asacolon [MeSH concept]
- ascolitin [MeSH concept]
- canasa [MeSH concept]
- claversal [MeSH concept]
- fivasa [MeSH concept]
- lixacol [MeSH concept]
- mesalamine [MeSH concept]
- mesalamine hydrochloride [MeSH concept]
- mesasal [MeSH concept]
- pentasa [MeSH concept]
- rowasa [MeSH concept]
Related MeSH Supplementary Concept(s)
- 5-amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-(1,2)dithiol-3yl)phenyl ester [MeSH Supplementary Concept]
- balsalazide [MeSH Supplementary Concept]
- butyrate, inulin, mesalamine drug combination [MeSH Supplementary Concept]
Related MeSH term(s)
- aminosalicylic acids [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing mesalazine (medicinal product) [SNOMED CT concept]
- sodium 5-aminosalicylate [Substance BNPC]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 5-aminosalicylic acid [Substance BNPC]
- Mesalamine [NCIt concept]
- Mesalazine [ICD-11 Extension code]
- Mesalazine (substance) [SNOMED CT concept]
- Product containing mesalazine (medicinal product) [SNOMED CT concept]
- mesalamine [SNOMED Notion]
- mesalazine [ATC Code]
Validated automatic mappings to BTNT
- 5-Aminosalicylate [LOINC component]
- mesalazine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients